文献速递血栓与止血

血栓调节蛋白(THBD)基因变异与血栓风险的人群队列研究

Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study.
PubMed 文献 · J Thromb Haemost · 2022-01-12

在马尔默饮食与癌症研究(1991—1996年)28,794名中老年人中分析THBD外显子序列,常见变异rs1042579与VTE无关联;罕见合格变异经Cox多因素校正后与VTE风险相关,风险比3.0(95%CI 1.4-6.3)。

要点

  • 常见编码变异rs1042579与发生VTE无关联。
  • 16个罕见变异纳入合并分析,7例VTE者携带合格变异,而无VTE者为24例。
  • 罕见合格变异与VTE相关,风险比3.0(95%CI 1.4-6.3)。

核心结论

  • 罕见合格THBD变异与VTE相关,提示THBD罕见变异可能参与VTE发生。

研究设计与样本

  • 基于马尔默饮食与癌症研究(1991—1996年)的人群队列,分析28,794名受试者(出生于1923—1950年,60%为女性)的THBD外显子序列。
  • 合格变异定义为功能缺失或PolyPhen-2非良性错义变异,且次要等位基因频率<0.1%。
  • 随访自基线至首次VTE事件、死亡或2018年。

主要发现

  • 常见编码变异rs1042579与发生VTE无关联。
  • 16个罕见变异被归类为合格变异并纳入合并分析。
  • 7例发生VTE者与24例未发生VTE者各携带一个合格变异。
  • 校正年龄、性别、体重指数、收缩压、吸烟与饮酒、rs6025、rs1799963及主成分分析前两个特征向量后,罕见合格变异的风险比为3.0(95%CI 1.4-6.3)。
  • THBD合格变异在发生与未发生VTE个体中的分布存在差异,提示可能存在位置效应。

关键数值与推荐

  • 合格变异:功能缺失或PolyPhen-2非良性错义变异,次要等位基因频率<0.1%。
  • Cox多因素校正后罕见合格变异风险比3.0(95%CI 1.4-6.3)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The protein C anticoagulant system plays a key role in maintaining the hemostatic balance. Although several studies have identified thrombomodulin gene (THBD) variants among venous thromboembolism (VTE) patients, the role of THBD in relation to VTE in humans remains to be clarified. OBJECTIVES: This study aimed to determine the thrombotic risk of rare and common THBD variants in a large population-based cohort of middle-aged and older adults. PATIENTS/METHODS: The exome sequence of THBD was analyzed for qualifying variants in 28,794 subjects (born 1923-1950, 60% women), who participated in the Malmö Diet and Cancer study (1991-1996). Patients were followed from baseline until the first event of VTE, death, or 2018. Qualifying variants were defined as loss-of-function or non-benign (PolyPhen-2) missense variants with minor allele frequency <0.1%. RESULTS: The single common coding variant rs1042579 was not associated with incident VTE. Sixteen rare variants were classified as qualifying and included in collapsing analysis. Seven individuals with VTE compared to 24 individuals without VTE carried one qualifying variant. Cox multivariate regression analysis adjusted for age, sex, body mass index, systolic blood pressure, smoking and alcohol consumption, rs6025, rs1799963, and the top two eigenvectors from a principal components analysis showed a hazard ratio of 3.0 (95% confidence interval 1.4-6.3) for the rare qualifying variants. The distributions of qualifying variants in THBD showed a difference for individuals with and without incident VTE indicating a possible position effect. CONCLUSIONS: Rare qualifying THBD variants were associated with VTE, suggesting that rare variants in THBD contribute to development of VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Manderstedt E, Halldén C, Lind-Halldén C, et al. Thrombomodulin (THBD) gene variants and thrombotic risk in a population-based cohort study. J Thromb Haemost. 2022. PMID: 34970867. doi:10.1111/jth.15630

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。